Aurinia Pharmaceuticals
AUPH
#4884
Rank
C$2.97 B
Marketcap
C$22.34
Share price
-1.10%
Change (1 day)
39.15%
Change (1 year)

Market capitalization of Aurinia Pharmaceuticals (AUPH)

Market cap: C$2.97 Billion

As of September 2026 Aurinia Pharmaceuticals has a market cap of C$2.97 Billion. This makes Aurinia Pharmaceuticals the world's 4884th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aurinia Pharmaceuticals from 2009 to 2026

End of year Market Cap

Year Marketcap Change
2026C$2.97 B1.32%
2025C$2.93 B55.22%
2024C$1.89 B10.39%
2023C$1.71 B105.55%
2022C$0.83 B-77.96%
2021C$3.77 B70.06%
2020C$2.22 B-24.38%
2019C$2.93 B270.33%
2018C$0.79 B64.98%
2017C$0.48 B329.22%
2016C$0.11 B-0.23%
2015C$0.11 B-14.91%
2014C$0.13 B172.18%
2013C$48.49 M357.38%
2012C$10.6 M-49.01%
2011C$20.79 M-48.72%
2010C$40.55 M86.25%
2009C$21.77 M

End of Day market cap according to different sources

On Aug 31st, 2026 the market cap of Aurinia Pharmaceuticals was reported to be:

C$2.97 Billion
by Nasdaq info icon info icon
C$2.97 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
C$114.09 B 3,738.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
C$24.9 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
C$24.28 M-99.18%๐Ÿ‡บ๐Ÿ‡ธ USA